CN110478347B - 一种hc-1119制剂及其制备方法和用途 - Google Patents
一种hc-1119制剂及其制备方法和用途 Download PDFInfo
- Publication number
- CN110478347B CN110478347B CN201910394584.8A CN201910394584A CN110478347B CN 110478347 B CN110478347 B CN 110478347B CN 201910394584 A CN201910394584 A CN 201910394584A CN 110478347 B CN110478347 B CN 110478347B
- Authority
- CN
- China
- Prior art keywords
- preparation
- capsule
- parts
- androgen receptor
- receptor inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810458165 | 2018-05-14 | ||
CN2018104581651 | 2018-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110478347A CN110478347A (zh) | 2019-11-22 |
CN110478347B true CN110478347B (zh) | 2021-07-02 |
Family
ID=68539461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910394584.8A Active CN110478347B (zh) | 2018-05-14 | 2019-05-13 | 一种hc-1119制剂及其制备方法和用途 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210290553A1 (zh) |
EP (1) | EP3795153A4 (zh) |
JP (1) | JP7301883B2 (zh) |
KR (1) | KR102542275B1 (zh) |
CN (1) | CN110478347B (zh) |
AU (1) | AU2019268481A1 (zh) |
CA (1) | CA3105389A1 (zh) |
WO (1) | WO2019218979A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019184952A1 (en) * | 2018-03-29 | 2019-10-03 | Hinova Pharmaceuticals Inc. | Deuterated imidazolidinedione compounds and their uses |
CN114053243A (zh) * | 2020-08-05 | 2022-02-18 | 齐鲁制药有限公司 | 一种恩扎卢胺软胶囊及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104024228A (zh) * | 2011-12-14 | 2014-09-03 | 成都海创药业有限公司 | 咪唑二酮类化合物及其用途 |
CN104857517A (zh) * | 2015-05-14 | 2015-08-26 | 南京海纳医药科技有限公司 | 一种恩杂鲁胺软胶囊及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432090B (zh) * | 2015-10-30 | 2019-08-20 | 成都海创药业有限公司 | 一种氘代咪唑酮化合物的晶型及其制备方法和用途 |
CN107303278B (zh) * | 2016-04-25 | 2020-11-13 | 成都海创药业有限公司 | 一种hc-1119固体分散体及其制备方法 |
ES2899372T3 (es) * | 2017-02-13 | 2022-03-11 | Kangpu Biopharmaceuticals Ltd | Combinación de tratamiento del cáncer de próstata, composición farmacéutica y método de tratamiento |
-
2019
- 2019-05-13 KR KR1020207035068A patent/KR102542275B1/ko active IP Right Grant
- 2019-05-13 EP EP19803519.8A patent/EP3795153A4/en active Pending
- 2019-05-13 JP JP2020564111A patent/JP7301883B2/ja active Active
- 2019-05-13 US US17/055,862 patent/US20210290553A1/en active Pending
- 2019-05-13 WO PCT/CN2019/086694 patent/WO2019218979A1/zh active Application Filing
- 2019-05-13 CN CN201910394584.8A patent/CN110478347B/zh active Active
- 2019-05-13 CA CA3105389A patent/CA3105389A1/en active Pending
- 2019-05-13 AU AU2019268481A patent/AU2019268481A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104024228A (zh) * | 2011-12-14 | 2014-09-03 | 成都海创药业有限公司 | 咪唑二酮类化合物及其用途 |
CN104857517A (zh) * | 2015-05-14 | 2015-08-26 | 南京海纳医药科技有限公司 | 一种恩杂鲁胺软胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110478347A (zh) | 2019-11-22 |
KR20210006949A (ko) | 2021-01-19 |
JP2021523195A (ja) | 2021-09-02 |
EP3795153A4 (en) | 2022-03-09 |
AU2019268481A1 (en) | 2021-01-07 |
EP3795153A1 (en) | 2021-03-24 |
US20210290553A1 (en) | 2021-09-23 |
KR102542275B1 (ko) | 2023-06-12 |
CA3105389A1 (en) | 2019-11-21 |
WO2019218979A1 (zh) | 2019-11-21 |
JP7301883B2 (ja) | 2023-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4035657A1 (en) | Drug composition containing abiraterone acetate, and preparation method therefor and application thereof | |
CN110478347B (zh) | 一种hc-1119制剂及其制备方法和用途 | |
MX2010011295A (es) | Composiciones farmaceuticas orales en una dispersion solida que comprenden preferiblemente posaconazol y acetato-succinato de hidroxipropilmetilcelulosa. | |
EP2683361B2 (en) | Method for the preparaton of a levothyroxine solution | |
EP3943066A1 (en) | Abuse deterrent formulations of amphetamine | |
CN113164394B (zh) | 一种维拉佐酮固体分散体及其制备方法 | |
CN117919261A (zh) | 药物组合物、制备方法及其使用方法 | |
CN110478330A (zh) | 一种艾地骨化醇软胶囊及其制备方法 | |
CN103142515B (zh) | 一种细辛脑注射剂及其制备方法 | |
CN113750032A (zh) | 一种口服的阿比特龙药物组合物及其制备方法及用途 | |
CN107019680B (zh) | 一种雷贝拉唑钠肠溶胶囊的制备工艺 | |
US20230227456A1 (en) | Oral formulation comprising a crystalline form of rabeximod | |
RU2777008C2 (ru) | Состав hc-1119, способ его получения и применение | |
CN106860446A (zh) | 小儿复方氨基酸注射液19aa‑i 组合物及降低其氧含量的方法 | |
CN105520913B (zh) | 一种包含沙格列汀的微丸、其用途及其制备方法 | |
CN111450076A (zh) | 一种Lemborexant软胶囊组合物及其制备方法 | |
CN110638764A (zh) | 一种坎地沙坦酯速释小丸 | |
CN104523691A (zh) | 一种高溶出度托匹司他药物组合物及其制备方法 | |
CN100402030C (zh) | 一种含阿莫西林的药物组合物及其制备方法 | |
CN106937944A (zh) | 一种注射用甲硝唑冻干粉针制剂及其制备方法 | |
CN114224832A (zh) | 一种恩杂鲁胺注射剂及其制备方法和应用 | |
CN105395554B (zh) | 一种叶酸固体分散体及其制备方法 | |
CN108125906B (zh) | 一种伊曲康唑滴剂及其制备方法 | |
CN104367583B (zh) | 一种生物利用度高的三氟柳药物组合物 | |
CN101703486A (zh) | 一种新型氟他胺片剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200721 Address after: Science Park high tech Zone of Chengdu South Road, No. 5 building 610000 Sichuan Province Rong medicine A 4 storey building No. 1 Applicant after: HINOVA PHARMACEUTICALS Inc. Applicant after: SICHUAN HAISCO PHARMACEUTICAL Co.,Ltd. Address before: Science Park high tech Zone of Chengdu South Road, No. 5 building 610000 Sichuan Province Rong medicine A 4 storey building No. 1 Applicant before: HINOVA PHARMACEUTICALS Inc. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.1, floor 4, building a, Rongyao building, No.5 Keyuan South Road, high tech Zone, Chengdu, Sichuan 610000 Applicant after: Haichuang Pharmaceutical Co.,Ltd. Applicant after: SICHUAN HAISCO PHARMACEUTICAL Co.,Ltd. Address before: No.1, floor 4, building a, Rongyao building, No.5 Keyuan South Road, high tech Zone, Chengdu, Sichuan 610000 Applicant before: HINOVA PHARMACEUTICALS Inc. Applicant before: SICHUAN HAISCO PHARMACEUTICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210309 Address after: No.1, floor 4, building a, Rongyao building, No.5 Keyuan South Road, high tech Zone, Chengdu, Sichuan 610000 Applicant after: Haichuang Pharmaceutical Co.,Ltd. Address before: No.1, floor 4, building a, Rongyao building, No.5 Keyuan South Road, high tech Zone, Chengdu, Sichuan 610000 Applicant before: Haichuang Pharmaceutical Co.,Ltd. Applicant before: SICHUAN HAISCO PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |